Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Abstract 1854: Treatment of head and neck squamous cell carcinoma cells with BMS754807 and Dasatinib induce synergistic cytotoxicity through altered focal adhesion signaling

Christine E. Lehman, Rolando MEndez, Mark Axelrod, Julia Wulfkuhle, Emanuel Petricoin, Daniel Gioeli, Mark Jameson

Cancer Res (2018) 78 (13_Supplement): 1854.

https://doi.org/10.1158/1538-7445.AM2018-1854

Published: 01 July 2018

View articletitled, Abstract 1854: Treatment of head and neck squamous cell carcinoma cells with BMS754807 and Dasatinib induce synergistic cytotoxicity through altered focal adhesion signaling

Journal Articles

Abstract 3747: Translating the functional interactions of checkpoint kinase 2 and the androgen receptor into more effective therapies for the treatment of prostate cancer

Huy Q. Ta, Natalia Dworak, Rosalie Sleppy, Jeffery A. Allende, Daniel Gioeli

Cancer Res (2018) 78 (13_Supplement): 3747.

https://doi.org/10.1158/1538-7445.AM2018-3747

Published: 01 July 2018

View articletitled, Abstract 3747: Translating the functional interactions of checkpoint kinase 2 and the androgen receptor into more effective therapies for the treatment of prostate cancer

Journal Articles

αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor

Huimin Lu, Tao Wang, Jing Li, Carmine Fedele, Qin Liu, Jianzhong Zhang, Zhong Jiang, Dhanpat Jain, Renato V. Iozzo, Shelia M. Violette, Paul H. Weinreb, Roger J. Davis, Daniel Gioeli, Thomas J. FitzGerald, Dario C. Altieri, Lucia R. Languino

Cancer Res (2016) 76 (17): 5163–5174.

https://doi.org/10.1158/0008-5472.CAN-16-0543

Published: 31 August 2016

View articletitled, αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor

Includes: Supplementary data

Journal Articles

Abstract 979: Identification of a novel long noncoding RNA within the LCK gene locus that regulates prostate cancer cell growth

Huy Q. Ta, Samuel R. Jackson, Hilary Whitworth, Shriti Bhadel, Daniel Gioeli

Cancer Res (2016) 76 (14_Supplement): 979.

https://doi.org/10.1158/1538-7445.AM2016-979

Published: 15 July 2016

View articletitled, Abstract 979: Identification of a novel long noncoding RNA within the LCK gene locus that regulates prostate cancer cell growth

Journal Articles

Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth

Huy Q. Ta, Melissa L. Ivey, Henry F. Frierson, Jr, Mark R. Conaway, Jaroslaw Dziegielewski, James M. Larner, Daniel Gioeli

Cancer Res (2015) 75 (23): 5093–5105.

https://doi.org/10.1158/0008-5472.CAN-15-0224

Published: 30 November 2015

View articletitled, Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth

Includes: Supplementary data

Journal Articles

Abstract 5049: Checkpoint kinase 2 is a novel regulator of prostate cancer cell growth

Huy Q. Ta, Melissa L. Ivey, Henry F. Frierson, Mark R. Conaway, Jaroslaw Dziegielewski, James M. Larner, Daniel Gioeli

Cancer Res (2015) 75 (15_Supplement): 5049.

https://doi.org/10.1158/1538-7445.AM2015-5049

Published: 01 August 2015

View articletitled, Abstract 5049: Checkpoint kinase 2 is a novel regulator of prostate cancer cell growth

Journal Articles

Abstract 5633: Co-targeting the IGF1R pathway and compensatory signaling enhances cytotoxicity in head and neck cancer.

Mark J. Axelrod, Daniel Gioeli, Elizabeth R. Sharlow, Mark C. Conaway, Rolando E. Mendez, Ashraf Khalil, Linnea Taniguchi, Emmanual F. Petricoin, Stephanie Leimgruber, Michael J. Weber, Mark J. Jameson

Cancer Res (2013) 73 (8_Supplement): 5633.

https://doi.org/10.1158/1538-7445.AM2013-5633

Published: 15 April 2013

View articletitled, Abstract 5633: Co-targeting the IGF1R pathway and compensatory signaling enhances cytotoxicity in head and neck cancer.

Journal Articles

Abstract 3577: The role of Checkpoint Kinase 2 in the regulation of androgen receptor signaling and prostate cancer cell growth during progression to castration resistance.

Huy Q. Ta, Melissa L. Ivey, Daniel Gioeli

Cancer Res (2013) 73 (8_Supplement): 3577.

https://doi.org/10.1158/1538-7445.AM2013-3577

Published: 15 April 2013

View articletitled, Abstract 3577: The role of Checkpoint Kinase 2 in the regulation of androgen receptor signaling and prostate cancer cell growth during progression to castration resistance.

Journal Articles

Abstract 1650: Targeting of compensatory signaling pathways identified in a synthetic lethal screen leads to synergistic growth inhibition in bladder cancer cells

Mark J. Axelrod, Daniel Gioeli, Michael J. Weber

Cancer Res (2010) 70 (8_Supplement): 1650.

https://doi.org/10.1158/1538-7445.AM10-1650

Published: 15 April 2010

View articletitled, Abstract 1650: Targeting of compensatory signaling pathways identified in a synthetic lethal screen leads to synergistic growth inhibition in bladder cancer cells

Journal Articles

Abstract 3843: Rational selection of combinatorial therapeutic targets for melanoma identified by synthetic lethal screening with small molecule inhibitors

Devin G. Roller, Kerrington R. Molhoek, Craig L. Slingluff, Michael J. Weber, Daniel Gioeli

Cancer Res (2010) 70 (8_Supplement): 3843.

https://doi.org/10.1158/1538-7445.AM10-3843

Published: 15 April 2010

View articletitled, Abstract 3843: Rational selection of combinatorial therapeutic targets for melanoma identified by synthetic lethal screening with small molecule inhibitors

Journal Articles

Abstract LB-201: Nuclear localization of Src, androgen receptor and PSA in prostate cancer

Parmita Saxena, Tao Wang, Dave S. Adams, Daniel Gioeli, Thomas J. FitzGerald, Lucia R. Languino

Cancer Res (2010) 70 (8_Supplement): LB-201.

https://doi.org/10.1158/1538-7445.AM10-LB-201

Published: 15 April 2010

View articletitled, Abstract LB-201: Nuclear localization of Src, androgen receptor and PSA in prostate cancer

Journal Articles

The Neuroendocrine-Derived Peptide Parathyroid Hormone–Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor

John DaSilva, Daniel Gioeli, Michael J. Weber, Sarah J. Parsons

Cancer Res (2009) 69 (18): 7402–7411.

https://doi.org/10.1158/0008-5472.CAN-08-4687

Published: 14 September 2009

View articletitled, The Neuroendocrine-Derived Peptide Parathyroid Hormone–Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor

Journal Articles

Abstract #5229: Neuroendocrine-derived PTHrP induces the stabilization of androgen receptor and promotes prostate cancer cell growth

John DaSilva, Daniel Gioeli, Michael Weber, Sarah Parsons, Sarah Parsons

Cancer Res (2009) 69 (9_Supplement): 5229.

Published: 01 May 2009

View articletitled, Abstract #5229: Neuroendocrine-derived PTHrP induces the stabilization of androgen receptor and promotes prostate cancer cell growth

Journal Articles

Abstract #LB-176: Site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src in prostate cancer cells

Yuanbo Liu, Mehmet Karaca, Zhentao Zhang, Nupam Mahajan, Daniel Gioeli, H. Shelton Earp, Young Whang

Cancer Res (2009) 69 (9_Supplement): LB-176.

Published: 01 May 2009

View articletitled, Abstract #LB-176: Site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src in prostate cancer cells

Journal Articles

CDK9 phosphorylation of the androgen receptor regulates transcriptional activity.

Vicki Gordon, JoAnn Zhang, Scott Ficarro, Sahana Mollah, Ioannis Xenarios, Donald Hunt, Michael Weber, Michael Carey, Daniel Gioeli

Cancer Res (2008) 68 (9_Supplement): 1577.

Published: 01 May 2008

View articletitled, CDK9 phosphorylation of the androgen receptor regulates transcriptional activity.

Journal Articles

A synthetic lethal screen to identify compensatory and/or redundant signaling pathways in cancer

Mark Axelrod, Adel Tarcsafasvi, Daniel Gioeli, Michael Weber

Cancer Res (2008) 68 (9_Supplement): 4176.

Published: 01 May 2008

View articletitled, A synthetic lethal screen to identify compensatory and/or redundant signaling pathways in cancer

Journal Articles

Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor

Sarah Kraus, Daniel Gioeli, Tomas Vomastek, Vicki Gordon, Michael J. Weber

Cancer Res (2006) 66 (22): 11047–11054.

https://doi.org/10.1158/0008-5472.CAN-06-0596

Published: 15 November 2006

View articletitled, Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor

Journal Articles

Constitutive Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway Promotes Androgen Hypersensitivity in LNCaP Prostate Cancer Cells

Robert E. Bakin, Daniel Gioeli, Robert A. Sikes, Eric A. Bissonette, Michael J. Weber

Cancer Res (2003) 63 (8): 1981–1989.

Published: 15 April 2003

View articletitled, Constitutive Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway Promotes Androgen Hypersensitivity in LNCaP Prostate Cancer Cells

Journal Articles

Attenuation of Ras Signaling Restores Androgen Sensitivity to Hormone-refractory C4-2 Prostate Cancer Cells

Robert E. Bakin, Daniel Gioeli, Eric A. Bissonette, Michael J. Weber

Cancer Res (2003) 63 (8): 1975–1980.

Published: 15 April 2003

View articletitled, Attenuation of Ras Signaling Restores Androgen Sensitivity to Hormone-refractory C4-2 Prostate Cancer Cells

Journal Articles

Activation of Mitogen-Activated Protein Kinase Associated with Prostate Cancer Progression

Daniel Gioeli, James W. Mandell, Gina R. Petroni, Henry F. Frierson, Jr., Michael J. Weber

Cancer Res (1999) 59 (2): 279–284.

Published: 15 January 1999

View articletitled, Activation of Mitogen-Activated Protein Kinase Associated with Prostate Cancer Progression

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 1854: Treatment of head and neck squamous cell carcinoma cells with BMS754807 and Dasatinib induce synergistic cytotoxicity through altered focal adhesion signaling

Abstract 3747: Translating the functional interactions of checkpoint kinase 2 and the androgen receptor into more effective therapies for the treatment of prostate cancer

αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor

Abstract 979: Identification of a novel long noncoding RNA within the LCK gene locus that regulates prostate cancer cell growth

Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth

Abstract 5049: Checkpoint kinase 2 is a novel regulator of prostate cancer cell growth

Abstract 5633: Co-targeting the IGF1R pathway and compensatory signaling enhances cytotoxicity in head and neck cancer.

Abstract 3577: The role of Checkpoint Kinase 2 in the regulation of androgen receptor signaling and prostate cancer cell growth during progression to castration resistance.

Abstract 1650: Targeting of compensatory signaling pathways identified in a synthetic lethal screen leads to synergistic growth inhibition in bladder cancer cells

Abstract 3843: Rational selection of combinatorial therapeutic targets for melanoma identified by synthetic lethal screening with small molecule inhibitors

Abstract LB-201: Nuclear localization of Src, androgen receptor and PSA in prostate cancer

The Neuroendocrine-Derived Peptide Parathyroid Hormone–Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor

Abstract #5229: Neuroendocrine-derived PTHrP induces the stabilization of androgen receptor and promotes prostate cancer cell growth

Abstract #LB-176: Site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src in prostate cancer cells

CDK9 phosphorylation of the androgen receptor regulates transcriptional activity.

A synthetic lethal screen to identify compensatory and/or redundant signaling pathways in cancer

Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor

Constitutive Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway Promotes Androgen Hypersensitivity in LNCaP Prostate Cancer Cells

Attenuation of Ras Signaling Restores Androgen Sensitivity to Hormone-refractory C4-2 Prostate Cancer Cells

Activation of Mitogen-Activated Protein Kinase Associated with Prostate Cancer Progression

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only